Kirt Tyson N.M.D
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Testosterone Replacement Therapy (TRT)
- Hormone Replacement Therapy (HRT)
- NAD IV Therapy
Washington, DC
Washington has a federal and lobbying professional class with full NP practice authority, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Georgetown, Dupont Circle, and Capitol Hill range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the GW Hospital, MedStar Georgetown, and Sibley Memorial network. The scene here skews toward concierge practices serving federal appointees, lobbyists, and diplomats. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Washington clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
Regulatory context
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting which peptides 503A compounding pharmacies may source. Section 503A covers patient-specific compounding pharmacies; Section 503B covers FDA-registered outsourcing facilities held to cGMP standards.
The DC Board of Pharmacy under the Department of Health inspects compounding facilities for USP compliance. Non-resident pharmacies serving DC patients must hold a non-resident permit. The District also coordinates with neighboring Maryland and Virginia regulators for clinics that operate across jurisdictions.